Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EASL Clinical Practice Guidelines: management of chronic hepatitis B.

× No keyword cloud information.

369 in total

1. Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.

Authors: Henry J Pollack; Simona C Kwon; Su H Wang; Laura C Wyatt; Chau Trinh-Shevrin
Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11 Impact factor: 4.254

Review 2. Interferon alpha for chronic hepatitis D.

Authors: Zaigham Abbas; Muhammad Arsalan Khan; Mohammad Salih; Wasim Jafri
Journal: Cochrane Database Syst Rev Date: 2011-12-07

Review 3. Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

Authors: Gillian M Keating
Journal: Drugs Date: 2011-12-24 Impact factor: 9.546

4. Cost effectiveness of tenofovir disoproxil fumarate for the treatment of chronic hepatitis B from a Canadian public payer perspective.

Authors: Helen Dakin; Morris Sherman; Scott Fung; Carrie Fidler; Anthony Bentley
Journal: Pharmacoeconomics Date: 2011-12 Impact factor: 4.981

5. Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda.

Authors: P Ocama; B Castelnuovo; M R Kamya; G D Kirk; S J Reynolds; A Kiragga; R Colebunders; D L Thomas
Journal: Int J STD AIDS Date: 2010-08 Impact factor: 1.359

Review 6. Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

Authors: Zhuo-Lun Song; Yu-Jun Cui; Wei-Ping Zheng; Da-Hong Teng; Hong Zheng
Journal: World J Gastroenterol Date: 2012-12-28 Impact factor: 5.742

7. Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures.

Authors: Yu Jin Kim; Dong Hyun Sinn; Geum-Youn Gwak; Moon Seok Choi; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Joon Hyeok Lee
Journal: World J Gastroenterol Date: 2012-12-21 Impact factor: 5.742

Review 8. Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review.

Authors: María Buti; Itziar Oyagüez; Virginia Lozano; Miguel A Casado
Journal: Pharmacoeconomics Date: 2013-01 Impact factor: 4.981

9. Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B.

Authors: Tae Jung Yun; Jin Yong Jung; Chang Ha Kim; Soon Ho Um; Hyonggin An; Yeon Seok Seo; Jin Dong Kim; Hyung Joon Yim; Bora Keum; Yong Sik Kim; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Chang Duck Kim; Ho Sang Ryu
Journal: World J Gastroenterol Date: 2012-12-21 Impact factor: 5.742

10. Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir.

Authors: Hana Park; Jun Yong Park; Seung Up Kim; Do Young Kim; Kwang-Hyub Han; Chae Yoon Chon; Sang Hoon Ahn
Journal: World J Gastroenterol Date: 2013 Impact factor: 5.742